Latest ARMAGEN Stories
ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome
ArmaGen to Receive up to Approximately $225 Million Including Initial Upfront Payment of $15 Million in Cash and Equity, an Additional Equity Investment, R&D Funding, Development and Sales Milestones,
Word of the Day
- An imitative word; an onomatopoetic word.
The word 'onomatope' is a back-formation from 'onomatopoeia'.